{"transactions":[{"id":907383,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:21.000Z","date":"2026-02-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":11296,"price":46.75,"value":528088.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs."}],"balance_after":197864,"source":{"system":"sec-edgar","filing":"0001699488-26-000002","document":"form4-02122026_040217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000169948826000002/form4-02122026_040217.xml","form_type":"4"}},{"id":907382,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:21.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":32531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Effective February 10, 2026, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 32,531 performance share units (\"PSUs\") granted in the Issuer's 2025 fiscal year."}],"balance_after":209160,"source":{"system":"sec-edgar","filing":"0001699488-26-000002","document":"form4-02122026_040217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000169948826000002/form4-02122026_040217.xml","form_type":"4"}},{"id":907381,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-12T21:30:21.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":79264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2027, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 376 shares acquired on July 18, 2025 under the Issuer's employee stock purchase plan."}],"balance_after":176629,"source":{"system":"sec-edgar","filing":"0001699488-26-000002","document":"form4-02122026_040217.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000169948826000002/form4-02122026_040217.xml","form_type":"4"}},{"id":959726,"issuer":{"id":3948,"kind":"organization","name":"Dyne Therapeutics, Inc.","symbol":"DYN"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-12-23T21:08:03.000Z","date":"2025-12-22","kind":"grant","planned":false,"acquired":true,"shares":59665,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on December 22, 2025. The shares underlying the option are scheduled to vest over three years in equal monthly installments through December 22, 2028."}],"balance_after":59665,"derivative":{"exercise_price":20.78,"expiration_date":"2035-12-21","underlying":"Common Stock","underlying_shares":59665},"source":{"system":"sec-edgar","filing":"0001193125-25-330863","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818794/000119312525330863/ownership.xml","form_type":"4"}},{"id":998767,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-11-14T21:13:00.000Z","date":"2025-11-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":8983,"price":47.35,"value":425345.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units."}],"balance_after":96989,"source":{"system":"sec-edgar","filing":"0001699488-25-000004","document":"form4-11142025_091156.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000169948825000004/form4-11142025_091156.xml","form_type":"4"}},{"id":1364961,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Purchase)","published_at":"2024-11-14T21:50:17.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":130344,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Twenty-five percent (25%) of the option shall vest and become exercisable on November 12, 2025, with the balance vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":130344,"derivative":{"exercise_price":31.41,"expiration_date":"2034-11-12","underlying":"Common Stock","underlying_shares":130344},"source":{"system":"sec-edgar","filing":"0001062993-24-019165","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324019165/form4.xml","form_type":"4"}},{"id":1364960,"issuer":{"id":5169,"kind":"organization","name":"COLLEGIUM PHARMACEUTICAL, INC"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-11-14T21:50:17.000Z","date":"2024-11-12","kind":"grant","planned":false,"acquired":true,"shares":105972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on November 12, 2025, with the balance vesting in three annual installments thereafter, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock."}],"balance_after":105972,"source":{"system":"sec-edgar","filing":"0001062993-24-019165","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1267565/000106299324019165/form4.xml","form_type":"4"}},{"id":2839228,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Ordinary Shares","published_at":"2021-02-23T18:20:36.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":645,"price":88.4502,"value":57050.379,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.14 to $88.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":104165,"source":{"system":"sec-edgar","filing":"0001209191-21-013382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121013382/doc4.xml","form_type":"4"}},{"id":2839227,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Ordinary Shares","published_at":"2021-02-23T18:20:36.000Z","date":"2021-02-22","kind":"sale","acquired":false,"shares":7713,"price":87.083,"value":671671.179,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.71 to $87.64 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":104810,"source":{"system":"sec-edgar","filing":"0001209191-21-013382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121013382/doc4.xml","form_type":"4"}},{"id":2846161,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2021-02-19T17:00:43.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":14512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on January 5, 2022 and the remaining one-third of the ordinary shares vest on January 5, 2023."}],"balance_after":14512,"derivative":{"underlying":"Ordinary Shares","underlying_shares":14512},"source":{"system":"sec-edgar","filing":"0001209191-21-012413","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121012413/doc4.xml","form_type":"4"}},{"id":2846160,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2021-02-19T17:00:43.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":3931,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."}],"balance_after":3931,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3931},"source":{"system":"sec-edgar","filing":"0001209191-21-012413","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121012413/doc4.xml","form_type":"4"}},{"id":2846159,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Ordinary Shares","published_at":"2021-02-19T17:00:43.000Z","date":"2021-02-17","kind":"tax_withholding","acquired":false,"shares":871,"price":87.17,"value":75925.07,"ownership":{"direct":true},"balance_after":112523,"source":{"system":"sec-edgar","filing":"0001209191-21-012413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121012413/doc4.xml","form_type":"4"}},{"id":2846158,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Ordinary Shares","published_at":"2021-02-19T17:00:43.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":1965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 17, 2021, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2022 and January 5, 2023."}],"balance_after":113394,"source":{"system":"sec-edgar","filing":"0001209191-21-012413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121012413/doc4.xml","form_type":"4"}},{"id":2899226,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2021-01-22T21:05:26.000Z","date":"2021-01-21","kind":"exercise","acquired":false,"shares":4904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."}],"balance_after":4905,"derivative":{"underlying":"Ordinary Shares","underlying_shares":4904},"source":{"system":"sec-edgar","filing":"0001209191-21-004998","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121004998/doc4.xml","form_type":"4"}},{"id":2899225,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Ordinary Shares","published_at":"2021-01-22T21:05:26.000Z","date":"2021-01-22","kind":"sale","acquired":false,"shares":2731,"price":76.81,"value":209768.11,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2020."}],"balance_after":111429,"source":{"system":"sec-edgar","filing":"0001209191-21-004998","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121004998/doc4.xml","form_type":"4"}},{"id":2899224,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Ordinary Shares","published_at":"2021-01-22T21:05:26.000Z","date":"2021-01-21","kind":"tax_withholding","acquired":false,"shares":2173,"price":77.43,"value":168255.39,"ownership":{"direct":true},"balance_after":114160,"source":{"system":"sec-edgar","filing":"0001209191-21-004998","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121004998/doc4.xml","form_type":"4"}},{"id":2899223,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Ordinary Shares","published_at":"2021-01-22T21:05:26.000Z","date":"2021-01-21","kind":"exercise","acquired":true,"shares":4904,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":116333,"source":{"system":"sec-edgar","filing":"0001209191-21-004998","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121004998/doc4.xml","form_type":"4"}},{"id":2912202,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Ordinary Shares","published_at":"2021-01-08T17:31:46.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":30031,"price":75,"value":2252325.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2020."}],"balance_after":111429,"source":{"system":"sec-edgar","filing":"0001209191-21-002786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002786/doc4.xml","form_type":"4"}},{"id":2915539,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-06T21:09:30.000Z","date":"2021-01-05","kind":"exercise","acquired":false,"shares":12094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."}],"balance_after":24190,"derivative":{"underlying":"Ordinary Shares","underlying_shares":12094},"source":{"system":"sec-edgar","filing":"0001209191-21-002414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002414/doc4.xml","form_type":"4"}},{"id":2915538,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-06T21:09:30.000Z","date":"2021-01-05","kind":"exercise","acquired":false,"shares":17260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2018."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17260},"source":{"system":"sec-edgar","filing":"0001209191-21-002414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002414/doc4.xml","form_type":"4"}},{"id":2915537,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-06T21:09:30.000Z","date":"2021-01-05","kind":"exercise","acquired":false,"shares":17983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."}],"balance_after":17983,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17983},"source":{"system":"sec-edgar","filing":"0001209191-21-002414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002414/doc4.xml","form_type":"4"}},{"id":2915536,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Restricted Stock Units (RSU)","published_at":"2021-01-06T21:09:30.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":20957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."}],"balance_after":20957,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20957},"source":{"system":"sec-edgar","filing":"0001209191-21-002414","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002414/doc4.xml","form_type":"4"}},{"id":2915535,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Ordinary Shares","published_at":"2021-01-06T21:09:30.000Z","date":"2021-01-05","kind":"tax_withholding","acquired":false,"shares":49906,"price":73.28,"value":3657111.68,"ownership":{"direct":true},"balance_after":141460,"source":{"system":"sec-edgar","filing":"0001209191-21-002414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002414/doc4.xml","form_type":"4"}},{"id":2915534,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Ordinary Shares","published_at":"2021-01-06T21:09:30.000Z","date":"2021-01-05","kind":"grant","acquired":true,"shares":65088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On January 5, 2018 and January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2021, the PSUs vested as to the number of shares reported above."}],"balance_after":191366,"source":{"system":"sec-edgar","filing":"0001209191-21-002414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002414/doc4.xml","form_type":"4"}},{"id":2915533,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Ordinary Shares","published_at":"2021-01-06T21:09:30.000Z","date":"2021-01-05","kind":"exercise","acquired":true,"shares":47337,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":126278,"source":{"system":"sec-edgar","filing":"0001209191-21-002414","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919121002414/doc4.xml","form_type":"4"}},{"id":3067419,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Stock Option (Right to buy)","published_at":"2020-08-05T13:24:41.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":11172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested and exercisable."}],"balance_after":72828,"derivative":{"exercise_price":22.14,"expiration_date":"2025-03-23","underlying":"Ordinary Shares","underlying_shares":11172},"source":{"system":"sec-edgar","filing":"0001209191-20-044992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120044992/doc4.xml","form_type":"4"}},{"id":3067418,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Stock Option (Right to buy)","published_at":"2020-08-05T13:24:41.000Z","date":"2020-08-03","kind":"exercise","acquired":false,"shares":25600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":9.23,"expiration_date":"2024-08-08","underlying":"Ordinary Shares","underlying_shares":25600},"source":{"system":"sec-edgar","filing":"0001209191-20-044992","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120044992/doc4.xml","form_type":"4"}},{"id":3067417,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Ordinary Shares","published_at":"2020-08-05T13:24:41.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":11172,"price":22.14,"value":247348.08,"ownership":{"direct":true},"balance_after":78941,"source":{"system":"sec-edgar","filing":"0001209191-20-044992","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120044992/doc4.xml","form_type":"4"}},{"id":3067416,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & President, International"}}],"security":"Ordinary Shares","published_at":"2020-08-05T13:24:41.000Z","date":"2020-08-03","kind":"exercise","acquired":true,"shares":25600,"price":9.23,"value":236288.0,"ownership":{"direct":true},"balance_after":67769,"source":{"system":"sec-edgar","filing":"0001209191-20-044992","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120044992/doc4.xml","form_type":"4"}},{"id":3126992,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-06-02T18:17:14.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":2369,"price":50.23,"value":118994.87,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,049 ordinary shares of the Issuer acquired by the reporting person on June 1, 2020 pursuant to an employee stock purchase program."}],"balance_after":42169,"source":{"system":"sec-edgar","filing":"0001209191-20-033715","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120033715/doc4.xml","form_type":"4"}},{"id":3166423,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-04-30T17:49:05.000Z","date":"2020-04-29","kind":"sale","acquired":false,"shares":15683,"price":35,"value":548905.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2020."}],"balance_after":43489,"source":{"system":"sec-edgar","filing":"0001209191-20-026399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120026399/doc4.xml","form_type":"4"}},{"id":3166422,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-04-30T17:49:05.000Z","date":"2020-04-28","kind":"sale","acquired":false,"shares":30063,"price":35.01,"value":1052505.63,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.07 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":59172,"source":{"system":"sec-edgar","filing":"0001209191-20-026399","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120026399/doc4.xml","form_type":"4"}},{"id":3256450,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2020-02-21T20:09:42.000Z","date":"2020-02-19","kind":"grant","acquired":true,"shares":30014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 5, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 19, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2021 and January 5, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 5, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 19, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2021 and January 5, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 5, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 19, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2021 and January 5, 2022."}],"balance_after":30014,"derivative":{"underlying":"Ordinary Shares","underlying_shares":30014},"source":{"system":"sec-edgar","filing":"0001209191-20-011833","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120011833/doc4.xml","form_type":"4"}},{"id":3256449,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-21T20:09:42.000Z","date":"2020-02-19","kind":"tax_withholding","acquired":false,"shares":6649,"price":36.06,"value":239762.94,"ownership":{"direct":true},"balance_after":89235,"source":{"system":"sec-edgar","filing":"0001209191-20-011833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120011833/doc4.xml","form_type":"4"}},{"id":3256448,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-21T20:09:42.000Z","date":"2020-02-19","kind":"grant","acquired":true,"shares":15007,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 5, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 19, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 5, 2021 and January 5, 2022."}],"balance_after":95884,"source":{"system":"sec-edgar","filing":"0001209191-20-011833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120011833/doc4.xml","form_type":"4"}},{"id":3256429,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2020-02-21T20:01:43.000Z","date":"2020-01-21","kind":"grant","acquired":true,"shares":9809,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 21, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 21, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 21, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."}],"balance_after":9809,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9809},"source":{"system":"sec-edgar","filing":"0001209191-20-011823","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120011823/doc4a.xml","form_type":"4/A","original_submission_date":"2020-01-23"}},{"id":3256428,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-21T20:01:43.000Z","date":"2020-01-21","kind":"tax_withholding","acquired":false,"shares":2173,"price":38.25,"value":83117.25,"ownership":{"direct":true},"balance_after":80877,"source":{"system":"sec-edgar","filing":"0001209191-20-011823","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120011823/doc4a.xml","form_type":"4/A","original_submission_date":"2020-01-23"}},{"id":3256427,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-02-21T20:01:43.000Z","date":"2020-01-21","kind":"grant","acquired":true,"shares":4904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 21, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."}],"balance_after":83050,"source":{"system":"sec-edgar","filing":"0001209191-20-011823","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120011823/doc4a.xml","form_type":"4/A","original_submission_date":"2020-01-23"}},{"id":3304063,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Performance Restricted Stock Units (PSUs)","published_at":"2020-01-23T16:18:28.000Z","date":"2020-01-21","kind":"grant","acquired":true,"shares":10708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each PSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 21, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 21, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 21, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."}],"balance_after":10708,"derivative":{"underlying":"Ordinary Shares","underlying_shares":10708},"source":{"system":"sec-edgar","filing":"0001209191-20-004656","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120004656/doc4.xml","form_type":"4"}},{"id":3304062,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-01-23T16:18:28.000Z","date":"2020-01-21","kind":"tax_withholding","acquired":false,"shares":2372,"price":38.25,"value":90729.0,"ownership":{"direct":true},"balance_after":81127,"source":{"system":"sec-edgar","filing":"0001209191-20-004656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120004656/doc4.xml","form_type":"4"}},{"id":3304061,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-01-23T16:18:28.000Z","date":"2020-01-21","kind":"grant","acquired":true,"shares":5353,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 4, 2019, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 21, 2020, such performance criteria were met, and the PSUs vested as to the number of shares reported in Table I above.  The remaining ordinary shares subject to the PSUs vest in equal annual installments on January 21, 2021 and January 21, 2022."}],"balance_after":83499,"source":{"system":"sec-edgar","filing":"0001209191-20-004656","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120004656/doc4.xml","form_type":"4"}},{"id":3316337,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2020-01-07T18:23:30.000Z","date":"2020-01-05","kind":"exercise","acquired":false,"shares":17260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2018."}],"balance_after":17260,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17260},"source":{"system":"sec-edgar","filing":"0001209191-20-002346","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120002346/doc4.xml","form_type":"4"}},{"id":3316336,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2020-01-07T18:23:30.000Z","date":"2020-01-05","kind":"exercise","acquired":false,"shares":17982,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."}],"balance_after":35966,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17982},"source":{"system":"sec-edgar","filing":"0001209191-20-002346","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120002346/doc4.xml","form_type":"4"}},{"id":3316335,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2020-01-07T18:23:30.000Z","date":"2020-01-03","kind":"grant","acquired":true,"shares":36284,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2020."}],"balance_after":36284,"derivative":{"underlying":"Ordinary Shares","underlying_shares":36284},"source":{"system":"sec-edgar","filing":"0001209191-20-002346","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120002346/doc4.xml","form_type":"4"}},{"id":3316334,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-01-07T18:23:30.000Z","date":"2020-01-06","kind":"sale","acquired":false,"shares":9297,"price":35.62,"value":331159.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.49 to $35.71 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":78146,"source":{"system":"sec-edgar","filing":"0001209191-20-002346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120002346/doc4.xml","form_type":"4"}},{"id":3316333,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-01-07T18:23:30.000Z","date":"2020-01-05","kind":"tax_withholding","acquired":false,"shares":24225,"price":36.1,"value":874522.5,"ownership":{"direct":true},"balance_after":87443,"source":{"system":"sec-edgar","filing":"0001209191-20-002346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120002346/doc4.xml","form_type":"4"}},{"id":3316332,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-01-07T18:23:30.000Z","date":"2020-01-05","kind":"grant","acquired":true,"shares":19014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On January 5, 2018, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On January 5, 2020, the PSUs vested as to the number of shares reported above."}],"balance_after":111668,"source":{"system":"sec-edgar","filing":"0001209191-20-002346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120002346/doc4.xml","form_type":"4"}},{"id":3316331,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2020-01-07T18:23:30.000Z","date":"2020-01-05","kind":"exercise","acquired":true,"shares":35242,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":92654,"source":{"system":"sec-edgar","filing":"0001209191-20-002346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919120002346/doc4.xml","form_type":"4"}},{"id":3467960,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-07-03T16:06:56.000Z","date":"2019-07-01","kind":"sale","acquired":false,"shares":13111,"price":25.0156,"value":327979.5316,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule10b5-1 trading plan adopted by the reporting person on June 5, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.00 to $25.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 2,369 ordinary shares of the Issuer acquired by the reporting person on May 31, 2019 pursuant to an employee stock purchase program."}],"balance_after":57412,"source":{"system":"sec-edgar","filing":"0001209191-19-041045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119041045/doc4.xml","form_type":"4"}},{"id":3579692,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2019-03-25T21:14:56.000Z","date":"2019-03-23","kind":"exercise","acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 23, 2015, the reporting person was granted 38,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 23, 2015, the reporting person was granted 38,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001209191-19-021270","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119021270/doc4.xml","form_type":"4"}},{"id":3579691,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-25T21:14:56.000Z","date":"2019-03-23","kind":"tax_withholding","acquired":false,"shares":4209,"price":26.84,"value":112969.56,"ownership":{"direct":true},"balance_after":68154,"source":{"system":"sec-edgar","filing":"0001209191-19-021270","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119021270/doc4.xml","form_type":"4"}},{"id":3579690,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-03-25T21:14:56.000Z","date":"2019-03-23","kind":"exercise","acquired":true,"shares":9500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":72363,"source":{"system":"sec-edgar","filing":"0001209191-19-021270","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119021270/doc4.xml","form_type":"4"}},{"id":3638741,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-22T17:27:21.000Z","date":"2019-02-20","kind":"tax_withholding","acquired":false,"shares":8622,"price":21.54,"value":185717.88,"ownership":{"direct":true},"balance_after":62863,"source":{"system":"sec-edgar","filing":"0001209191-19-012703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119012703/doc4.xml","form_type":"4"}},{"id":3638740,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-02-22T17:27:21.000Z","date":"2019-02-20","kind":"grant","acquired":true,"shares":19014,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 5, 2018, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 20, 2019, the PSUs vested as to the number of shares reported above, upon the Issuer's determination that certain performance criteria had been met."},{"field":"shares","element":"transactionShares","label":"F1","text":"On January 5, 2018, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On February 20, 2019, the PSUs vested as to the number of shares reported above, upon the Issuer's determination that certain performance criteria had been met."}],"balance_after":71485,"source":{"system":"sec-edgar","filing":"0001209191-19-012703","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119012703/doc4.xml","form_type":"4"}},{"id":3700237,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2019-01-08T20:41:46.000Z","date":"2019-01-05","kind":"exercise","acquired":false,"shares":17259,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2018."}],"balance_after":34520,"derivative":{"underlying":"Ordinary Shares","underlying_shares":17259},"source":{"system":"sec-edgar","filing":"0001209191-19-002937","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119002937/doc4.xml","form_type":"4"}},{"id":3700236,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2019-01-08T20:41:46.000Z","date":"2019-01-04","kind":"grant","acquired":true,"shares":53948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2019."}],"balance_after":53948,"derivative":{"underlying":"Ordinary Shares","underlying_shares":53948},"source":{"system":"sec-edgar","filing":"0001209191-19-002937","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119002937/doc4.xml","form_type":"4"}},{"id":3700235,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-08T20:41:46.000Z","date":"2019-01-05","kind":"tax_withholding","acquired":false,"shares":7962,"price":20.39,"value":162345.18,"ownership":{"direct":true},"balance_after":52471,"source":{"system":"sec-edgar","filing":"0001209191-19-002937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119002937/doc4.xml","form_type":"4"}},{"id":3700234,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2019-01-08T20:41:46.000Z","date":"2019-01-05","kind":"exercise","acquired":true,"shares":17259,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":60433,"source":{"system":"sec-edgar","filing":"0001209191-19-002937","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919119002937/doc4.xml","form_type":"4"}},{"id":3856810,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2018-08-01T21:05:09.000Z","date":"2018-07-31","kind":"exercise","acquired":false,"shares":5675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. The restricted stock units vest 25% annually on each anniversary of the vesting commencement date (July 31, 2014)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. The restricted stock units vest 25% annually on each anniversary of the vesting commencement date (July 31, 2014)."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5675},"source":{"system":"sec-edgar","filing":"0001209191-18-044823","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919118044823/doc4.xml","form_type":"4"}},{"id":3856809,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2018-08-01T21:05:09.000Z","date":"2018-07-31","kind":"tax_withholding","acquired":false,"shares":1663,"price":17.63,"value":29318.69,"ownership":{"direct":true},"balance_after":43174,"source":{"system":"sec-edgar","filing":"0001209191-18-044823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919118044823/doc4.xml","form_type":"4"}},{"id":3856808,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2018-08-01T21:05:09.000Z","date":"2018-07-31","kind":"exercise","acquired":true,"shares":5675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,371 ordinary shares of the Issuer acquired by the reporting person on June 1, 2018 pursuant to an employee stock purchase program."}],"balance_after":44837,"source":{"system":"sec-edgar","filing":"0001209191-18-044823","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919118044823/doc4.xml","form_type":"4"}},{"id":3944328,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2018-05-07T20:46:39.000Z","date":"2018-05-03","kind":"grant","acquired":true,"shares":51779,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."},{"field":"date","element":"transactionDate","label":"F2","text":"The RSU's were approved by the Issuer's Compensation Committee on January 5, 2018, subject to shareholder approval of certain amendments to the Issuer's 2014 Equity Incentive Plan (the \"Plan\") under which the RSU's were granted. The Issuer's shareholders approved the amendments to the Plan on May 3, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSU's vest 1/3rd annually on each anniversary of January 5, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":51779,"derivative":{"underlying":"Ordinary Shares","underlying_shares":51779},"source":{"system":"sec-edgar","filing":"0001209191-18-028489","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919118028489/doc4.xml","form_type":"4"}},{"id":3981915,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2018-03-27T17:34:33.000Z","date":"2018-03-23","kind":"exercise","acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 23, 2015, the reporting person was granted 38,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 23, 2015, the reporting person was granted 38,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":9500,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001209191-18-021796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919118021796/doc4.xml","form_type":"4"}},{"id":3981914,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-27T17:34:33.000Z","date":"2018-03-23","kind":"tax_withholding","acquired":false,"shares":4209,"price":13.86,"value":58336.74,"ownership":{"direct":true},"balance_after":36791,"source":{"system":"sec-edgar","filing":"0001209191-18-021796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919118021796/doc4.xml","form_type":"4"}},{"id":3981913,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2018-03-27T17:34:33.000Z","date":"2018-03-23","kind":"exercise","acquired":true,"shares":9500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":41000,"source":{"system":"sec-edgar","filing":"0001209191-18-021796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919118021796/doc4.xml","form_type":"4"}},{"id":4248450,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Rheumatology Bus. Unit"}}],"security":"Restricted Stock Units","published_at":"2017-07-31T19:00:38.000Z","date":"2017-07-31","kind":"exercise","acquired":false,"shares":5675,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. The restricted stock units vest 25% annually on each anniversary of the vesting commencement date (July 31, 2014)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. The restricted stock units vest 25% annually on each anniversary of the vesting commencement date (July 31, 2014)."}],"balance_after":5675,"derivative":{"underlying":"Ordinary Shares","underlying_shares":5675},"source":{"system":"sec-edgar","filing":"0001209191-17-046817","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919117046817/doc4.xml","form_type":"4"}},{"id":4248449,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Rheumatology Bus. Unit"}}],"security":"Ordinary Shares","published_at":"2017-07-31T19:00:38.000Z","date":"2017-07-31","kind":"tax_withholding","acquired":false,"shares":2662,"price":11.98,"value":31890.76,"ownership":{"direct":true},"balance_after":31500,"source":{"system":"sec-edgar","filing":"0001209191-17-046817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919117046817/doc4.xml","form_type":"4"}},{"id":4248448,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Rheumatology Bus. Unit"}}],"security":"Ordinary Shares","published_at":"2017-07-31T19:00:38.000Z","date":"2017-07-31","kind":"exercise","acquired":true,"shares":5675,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,428 ordinary shares of the Issuer acquired by the reporting person on June 1, 2017 pursuant to an employee stock purchase program."}],"balance_after":34162,"source":{"system":"sec-edgar","filing":"0001209191-17-046817","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919117046817/doc4.xml","form_type":"4"}},{"id":4372562,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Rheumatology Bus. Unit"}}],"security":"Restricted Stock Units","published_at":"2017-03-24T18:30:10.000Z","date":"2017-03-23","kind":"exercise","acquired":false,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 23, 2015, the reporting person was granted 38,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 23, 2015, the reporting person was granted 38,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":19000,"derivative":{"underlying":"Ordinary Shares","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001209191-17-022837","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919117022837/doc4.xml","form_type":"4"}},{"id":4372561,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Rheumatology Bus. Unit"}}],"security":"Ordinary Shares","published_at":"2017-03-24T18:30:10.000Z","date":"2017-03-23","kind":"tax_withholding","acquired":false,"shares":2955,"price":14.56,"value":43024.8,"ownership":{"direct":true},"balance_after":27059,"source":{"system":"sec-edgar","filing":"0001209191-17-022837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919117022837/doc4.xml","form_type":"4"}},{"id":4372560,"issuer":{"id":109157,"kind":"organization","name":"Horizon Therapeutics Public Ltd Co","symbol":"HZNP"},"owners":[{"id":66691,"kind":"person","name":"Karnani Vikram","position":1,"cik":"0001699488","reported_name":"Karnani Vikram","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Rheumatology Bus. Unit"}}],"security":"Ordinary Shares","published_at":"2017-03-24T18:30:10.000Z","date":"2017-03-23","kind":"exercise","acquired":true,"shares":9500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer."}],"balance_after":30014,"source":{"system":"sec-edgar","filing":"0001209191-17-022837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1492426/000120919117022837/doc4.xml","form_type":"4"}}]}